Plan terms and billing cadence shown before checkout.
← Back to Blog
Verification checklist

Before Using a Semaglutide Prescription: Verify the Instructions

By Kind MD Editorial Team|August 11, 2026|9 min read
Last updated: August 11, 2026
Prescription verification checklist for semaglutide
KEY TAKEAWAYS
In This Article
  1. Why verification matters
  2. What to verify
  3. When to pause and ask

Why verification matters

FDA has warned about dosing errors associated with compounded injectable semaglutide. The FDA alert describes errors involving different concentrations, containers, syringes, and unit measurements. This page does not reproduce a conversion or tell you how to administer a medicine.

The product label and dispensing-pharmacy materials are the controlling instructions for your prescription. A branded-product label is not a substitute for the instructions that accompany a compounded preparation.

What to verify before use

No numbers, unit conversions, injection sites, needle instructions, storage directions, or step-by-step technique belong in this general checklist. Those details are product- and prescription-specific.

When to pause and ask

Pause and contact the prescribing provider or dispensing pharmacy before using the product if the label, container, concentration, measurement language, or pharmacy identity is unclear or does not match your materials. FDA’s information on unapproved GLP-1 drugs also directs patients to their doctor, compounder, or telehealth platform with questions about instructions or labels.

Kind MD is a telehealth platform that connects eligible patients with licensed healthcare providers who may prescribe compounded semaglutide or tirzepatide when clinically appropriate. The information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Need help finding the right question?

Bring your prescription materials to a licensed provider or pharmacy.

Take the Free Quiz →
Published by the Kind MD Editorial Team This educational article is not a substitute for professional medical advice, diagnosis, or treatment.

Frequently asked questions

Is this page an injection tutorial?

No. It is a pre-use verification checklist. Follow your own prescription and pharmacy materials.

Why does FDA warn about compounded semaglutide dosing errors?

FDA reports errors involving differences in concentration, containers, syringes, and unit measurements. The alert explains why the exact prescription and pharmacy instructions must match.

Can I use a conversion from this page?

No. This page gives no conversions or dosing instructions. Ask the prescribing provider or dispensing pharmacy before using the product.

What should I do if the label and container do not match?

Pause and contact the dispensing pharmacy or prescribing provider before using the product.

Where should I get administration instructions?

Use the instructions supplied with your prescription and contact the prescribing provider or dispensing pharmacy with questions.

References

  1. FDA, Dosing Errors Associated with Compounded Injectable Semaglutide. Source
  2. FDA, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Source
  3. FDA, Current Wegovy Prescribing Information. Source

How to use this page

Kind MD articles are educational resources. We link to primary FDA sources and state what each source can and cannot establish. This page is not a substitute for professional medical advice, diagnosis, or treatment.

Questions about a prescription should go to your licensed healthcare provider and dispensing pharmacy.

Questions about your care?

Take the free quiz to get started. An independent licensed provider will review your information and determine whether treatment may be appropriate for you.

Take the Free Quiz →